Breaking News

Global access to cystic fibrosis drugs; a push to penalize Roche for cancer drug pricing

  

 

Pharmalot Ed Silverman

STAT+: Cost of a Vertex drug could worsen the global disparities in cystic fibrosis treatment, study finds

By Ed Silverman

Bill Sikes/AP

An analysis finds just 12% of people estimated to be living with cystic fibrosis in nearly 100 countries can access a highly effective drug.

Read More

STAT+: South Africa's antitrust regulator wants Roche penalized for 'excessive' cancer drug pricing

By Ed Silverman

Jeff J Mitchell/Getty Images

"The impact of excessive pricing falls heavily on women, particularly poor women, who cannot access essential treatment," the agency explained

Read More

STAT+: Thirty Madison and Nurx to merge, as digital pharmacy companies outgrow their origins

By Mario Aguilar

Alissa Ambrose/STAT

Thirty Madison and Nurx announced Wednesday they intend to merge, hinting at the increasing maturity in the digital pharmacy market.

Read More

The fall of Eric Lander and the end of science's 'big ego' era

By Matthew Herper

Claudio Cruz/AP

For years, Eric Lander's camera-grabbing persona and big achievements were enough to grant indulgence for just about any sin. No more.

Read More

Wednesday, February 9, 2022

STAT

Facebook   Twitter   YouTube   Instagram

1 Exchange Pl, Suite 201, Boston, MA 02109
©2022, All Rights Reserved.
I no longer wish to receive STAT emails
Update Email Preferences | Contact Us | View In Browser

No comments